Expression of the GALV fusogenic envelope glycoprotein from a replication competent Ad5 based vector promoted cell-cell fusion, enhanced cancer cell killing in vitro and reduced tumor burden in mice harbouring tumor xenografts, relative to the control virus [9]. The gene discussed is ERVW-1; the disease is neoplasm.